You wont know which
[DOI] [PubMed] [Google Scholar] 18.Michlig S., Merlini J.M., Beaumont M., Ledda M., Tavenard A., Mukherjee R., Camacho S., le Coutre J
5.1.2 Effects on satiety In an exploratory, phase I study, oral semaglutide was found to reduce hunger, cravings for high-fat foods, and calorie consumption in patients with T2D [63], consistent with results from an earlier study of subcutaneous semaglutide in patients with obesity [64]
National Institutes of Health (NIH) PMC Medical Library on Semaglutide Advanced Dosing Progression Outcomes, Chronic Weight Control Studies, Gastric Clearing Rates, and Advanced Metabolic Reconditioning
These tests are not standard and are only done when necessary for medical, legal, or research needs